This edition will feature the following themes:
- Next-Generation RNA Therapies: From mRNA to Circular RNA
- Exploring the Future of CARs (ex vivo & in vivo)
- Gene Editing: Shaping the Future Today
- EVs and the Secretome: From Biology to Therapy
- Quality and Technical Challenges in Advanced Therapies
Speakers already confirmed
Massimiliano Gnecchi
PI, Associate Professor
Università di Pavia
Inna Menkova
CEO
Allogenica
Carmen Sanges
Executive Board Member
T2EVOLVE
Philippe Mangeot
Researcher
CIRI - International Center for Infectiology Research
Chantal Lagresle
Researcher
Imagine Institute
Alexandre Hill
CEO
Serendip innovations
Boris Greber
Managing Director
Catalent Pharma Solutions
